Wave Life Ownership
| WVE Stock | USD 12.06 0.15 1.26% |
Shares in Circulation | First Issued 2014-09-30 | Previous Quarter 129.5 M | Current Value 132.6 M | Avarage Shares Outstanding 50.5 M | Quarterly Volatility 35.3 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Wave |
Wave Stock Ownership Analysis
About 15.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 1.12. Wave Life Sciences had not issued any dividends in recent years. Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company was incorporated in 2012 and is based in Singapore. Wave Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people. For more information please call MBA MD at 65 6236 3388 or visit https://www.wavelifesciences.com.Besides selling stocks to institutional investors, Wave Life also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Wave Life's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Wave Life's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Wave Life Quarterly Liabilities And Stockholders Equity |
|
Wave Life Insider Trades History
About 15.0% of Wave Life Sciences are currently held by insiders. Unlike Wave Life's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Wave Life's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Wave Life's insider trades
Wave Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Wave Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Wave Life Sciences backward and forwards among themselves. Wave Life's institutional investor refers to the entity that pools money to purchase Wave Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Vanguard Group Inc | 2024-09-30 | 2.9 M | Emerald Advisers, Llc | 2024-09-30 | 2.9 M | Primecap Management Company | 2024-09-30 | 2.6 M | State Street Corp | 2024-09-30 | 2.3 M | Geode Capital Management, Llc | 2024-09-30 | 2.3 M | Emerald Mutual Fund Advisers Trust | 2024-09-30 | 2.1 M | Artisan Partners Limited Partnership | 2024-09-30 | 2 M | Fmr Inc | 2024-09-30 | 1.5 M | Affinity Asset Advisors, Llc | 2024-09-30 | 1.4 M | Ra Capital Management, Llc | 2024-09-30 | 18.2 M | Maverick Capital Ltd | 2024-09-30 | 10 M |
Wave Life Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Wave Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Wave Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Wave Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chandra Vargeese few days ago Acquisition by Chandra Vargeese of 60000 shares of Wave Life at 2.83 subject to Rule 16b-3 | ||
Chandra Vargeese six days ago Disposition of 46000 shares by Chandra Vargeese of Wave Life at 2.48 subject to Rule 16b-3 | ||
Chandra Vargeese over six months ago Acquisition by Chandra Vargeese of 50000 shares of Wave Life at 10.48 subject to Rule 16b-3 | ||
Adrian Rawcliffe over six months ago Acquisition by Adrian Rawcliffe of 45000 shares of Wave Life at 4.58 subject to Rule 16b-3 | ||
Chandra Vargeese over six months ago Acquisition by Chandra Vargeese of 361700 shares of Wave Life subject to Rule 16b-3 | ||
Ken Takanashi over a year ago Acquisition by Ken Takanashi of 45000 shares of Wave Life subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Sale by Chandra Vargeese of 10249 shares of Wave Life |
Wave Life Outstanding Bonds
Wave Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Wave Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Wave bonds can be classified according to their maturity, which is the date when Wave Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Wave Life Corporate Filings
F4 | 24th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 13th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
ASR | 12th of November 2024 Automatic Shelf Registration Statement under Rule 415 filed with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.